Bioavlee: 98% accurate software for automated bacterial colony counting

bioavlee logo white.png

Bioavlee: innovators in automated bacterial colony counting

Bioavlee is a biotechnology company developing advanced hardware and software solutions for automated bacterial colony counting. Its proprietary laser‑based imaging technology enables high‑precision acquisition of bacterial samples, which are then analyzed using machine learning models to identify and count colonies with laboratory‑grade accuracy. The solution significantly reduces manual workload while maintaining the level of accuracy required in highly regulated laboratory environments.

Key insights

target.svg

98% validated accuracy in image‑based bacterial colony counting

data.svg

50,000+ labeled images in the training dataset

training.svg

4 weeks to develop and validate the first production‑ready MVP

The challenge: scaling accuracy in a regulated environment

Bioavlee’s core expertise lies in laboratory instrumentation and optical hardware. While the initial software performed reliably in controlled, small‑scale laboratory settings, scaling the system exposed significant challenges. As Bioavlee operates in a highly regulated environment, any degradation in accuracy or reproducibility posed unacceptable risk. Early attempts to scale revealed several issues common to real‑world medical datasets: • label noise introduced during manual annotation; • class imbalance between bacterial strains; • data drift as new samples were introduced. At scale, model performance dropped to ~60% accuracy on datasets exceeding 50,000 images - well below acceptable thresholds for production use. Bioavlee needed a partner capable of building reproducible, scalable, and validation‑ready ML software, with transparent evaluation processes suitable for external audits and regulatory review.

bioavle.png

The solution: cross‑functional ML and domain collaboration

Bioavlee partnered with Codewave to redesign and harden their image recognition software. The collaboration began with in‑depth Exploratory Data Analysis (EDA) workshops involving both Codewave’s software engineers and Bioavlee’s domain experts. This phase established a shared understanding of laboratory constraints, data characteristics, and regulatory requirements. Codewave then executed a structured improvement program combining: • disciplined data curation and relabeling workflows • close collaboration with domain experts • deep neural network (DNN) optimization • statistically rigorous validation and hold‑out testing Within the first four weeks, the joint team increased model accuracy from 60% to 82% and delivered a roadmap toward full production readiness.

Codewave quickly became an integral part of our organization. Their team combined deep ML expertise with the ability to truly understand our laboratory domain. The value of applying neural networks became clear immediately.

Michal Wronecki
CEO, Bioavlee

Used technologies

deepl 1.svg

Deep Neural Networks (DNNs)

for image‑based colony detection and counting

nvidia.svg

On‑premise NVIDIA GPU servers

for sensitive and validation‑critical workloads

Amazon EC2.svg

Amazon EC2 (p2.8xlarge, Spot Instances)

for scalable and cost‑efficient training

analysis.svg

Machine Learning

with strict separation of training, validation, and test data

The results: repeatable ML validation and 98% accuracy

Over the following six months, Codewave and Bioavlee collaborated on continuous model refinement, data quality improvements, and evaluation methodology. Key outcomes included: • a repeatable training and validation pipeline • strict hold‑out testing to control overfitting • transparent, reproducible metrics suitable for external review This iterative process increased model accuracy from 60% to 98%, while ensuring statistical robustness and long‑term maintainability. Additionally, the introduction of hybrid training workflows, connecting on‑premise GPUs with AWS resources, enabled scalable experimentation without compromising reproducibility or cost control.

Other Case Studies

CDWV_Case study_wystawi.png

Wystawi.AI Mobile App for Doctors

How do you improve the lives of thousands with a headless CMS? By saving their time on everyday routines. Wystawi.AI is a mobile app for doctors developed by CodeWave that streamlines the process of e-prescribing from 14 steps to approximately 30 seconds. Integrated with pacjent.gov.pl and the National Register of Medicinal Products, and fully compliant with Polish law. An AI voice assistant, biometric authentication, and Flotiq Headless CMS as the content backbone speed up rollouts and updates.

Read more
CDWV_Case study_verizon.png

Game of Thrones quizz-like app

Once again we helped with an online promotion of a movie. When the final season of Game of Thrones aired its first episode - we delivered a quizz-like app to help promote it in social media.

Read more
CDWV_Case study_royal canin.png

CMS solution capable of handling high traffic

Royal Canin, a French company specializing in high-quality pet food, required a robust CMS solution capable of handling high traffic and providing seamless user experience. Codewave was brought in early in the project to rescue the implementation and deliver a high-performance platform.

Read more

We create bespoke solutions and products tailored to your needs

Let’s talk about your current challenge and see where we can help. 

Book a call with our engineers

CONTACT

  • [email protected]
  • Europe: Codewave sp. z o.o.; Opolska Str. 13, 52-010 Wrocław, Poland; +48 539 019 430

  • USA: Codewave LLC; 16192 Coastal Hwy, Lewes,
DE 19958, United States; +1 (631) 909 5771


LogoCodewave. All Right Reserved 2026
  • github.svg
  • linkedin.svg
ue.png